GILEAD SCIENCES, INC. — Director's Dealing 2014

May 8, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2014-05-06

Reporting Person: Cogan John Francis (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-06	Common Stock	M	2863	—	Acquired	42405	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-06	Restricted Stock Units	$	M	2863	Disposed		Common Stock (2863)	Direct
2014-05-07	Restricted Stock Units	$	A	1904	Acquired		Common Stock (1904)	Direct
2014-05-07	Non-Qualified Stock Options (Right to Buy)	$78.77	A	4868	Acquired	2024-05-07	Common Stock (4868)	Direct

Footnotes

F1: Options vest quarterly over the first year of service upon the earlier of May 7, 2015, or the day immediately preceding the next regular annual stockholders meeting.

F2: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3: 100% of the restricted stock units will vest upon the earlier of May 7, 2015, or the day immediately preceding the next regular annual stockholders meeting.

F4: 100% of the restricted stock units vested on May 6, 2014.